C09990180 / invoice 10000
Species:CANINE
Breed:American Staffordshire Terrier
Age (years):9
Diagnosis or signs:See notes
Consult notes
05/03/2026 HISTORY: Presented for: EXAM: Mentation: BCS: Hydration status: Eyes: Ears: Nose: Mouth: MM: Throat: LNs: CV: HR: Resp: Abdo: MSK: Integ: Neuro: Genitourinary: Rectal: T: ASSESSMENT: PLAN: COMMUNICATION:
Animal clinical history (3 most recent)
2026-03-05T00:00:00Z 12:51:41
HISTORY: Presented for: EXAM: Mentation: BCS: Hydration status: Eyes: Ears: Nose: Mouth: MM: Throat: LNs: CV: HR: Resp: Abdo: MSK: Integ: Neuro: Genitourinary: Rectal: T: ASSESSMENT: PLAN: COMMUNICATION:
2026-01-21T00:00:00Z 14:34:18
HISTORY: Presented for echo; recently auscultated murmur Well at home, breathing normally EXAMINATION: *DOG REACTIVE* but O reports good with people BAR, BCS 6/9, T not taken Eyes NAD Ears NAD Oral mild tartar and gingivitis MM pink, CRT 1.5s HR 120, grade III/VI murmur RR 20, NAD Abdomen comfortable LN WNL Integ NAD ECHOCARDIOGRAM Sedation: butorphanol 0.72ml IV, insufficient sedation so administered further butorphanol 0.35ml IV, still insufficient sedation so administered ACP 0.18ml IV Report: B-mode (each figure averaged over a minimum of 3 measurements, unless otherwise specified) LA (LAx) 39.8 mm Ao (LAx) 19.1 mm LA:Ao (LAx) 2.08 (normal <2.6) LA (SAx) 27.15 mm Ao (SAx) 20.67 mm LA:Ao (SAx) 1.31 (normal <1.6) PA:Ao approx 1:1 M-mode (each figure averaged over a minimum of 3 measurements, unless otherwise specified) IVSd 13.16 mm LVIDd 48.86 mm LVPWd 11.23 mm IVSs 17.86 mm LVIDs 34.73 mm LVPWs 15.1 mm FS 28.9 % Doppler PA Vmax 0.64 m/s (normal <1.4 – 1.8) Ao Vmax 0.76 m/s (normal <2) MR Vmax unable to measure (suboptimal alignment, and jet quite small) Sonographic findings: - normal left atrial size and normal LA/Ao - mild mitral regurgitation - mitral valve thickening with no prolapse - very mild left ventricular dilation during diastole and systole = Stage B1 myxomatous mitral valve disease (MMVD) Comments: The findings are consistent with stage B1 MMVD. No medications are currently indicated. Ongoing monitoring of resting respiratory rate is recommended (normal is <30 breaths per minute, obtained when patient is calm or asleep). A repeat echo is recommended in 6-12mths, sooner if clinically indicated (e.g, increased respiratory effort, increased respiratory rate, coughing, reduced exercise tolerance). TREATMENT/ TREATMENT PLAN: Nil COMMUNICATION: 1545 SZ STO with update and discussed findings as above; no meds currently indicated 1800 SZ realised at discharge forgot to obtain pre-GA bloods - expressed my sincere apologies; Os very gracious; took it very well and were unbothered
2025-12-31T00:00:00Z 11:24:52
SUBJECTIVE: Had surgery prior this year. On gabapentin and trazodone New Year eve fireworks. Also warts to be examined. Squeeze anal glands OBJECTIVE: T 38.6 HR 120 Grade 3 murmur. MM pink CRT < 2sec ASSESSMENT: Heart murmur- needs echo Continue Apoquel. PLAN: Kalma 4 mg prior tpo FW CLIENT COMMUNICATION: Medicate as direcdted. Can give additional gaba If Kalma not eniough.
Previous claim history (4)
| Date | Claim # | Diagnosis |
|---|---|---|
| 2026-01-21 | C09792294 | MITRAL VALVE MYXOMATOUS DEGENERATION |
| 2025-12-31 | C09693951 | HEART MURMUR |
| 2025-12-31 | C09693951 | BEHAVIOUR DISORDER |
| 2025-12-31 | C09693951 | HYPERSENSITIVITY (ALLERGIC) SKIN DISORDER |
Line items(lines with upstream diagnosis are skipped by the model)
| Line | tstarc | Amount | Date | Upstream diagnosis |
|---|---|---|---|---|
| 10000 | tstarc_consultation-emergency/afterhours | 165.00 | 2026-03-05 | — |
| 20000 | tstarc_diagnostic_test_-_urine_test | 95.00 | 2026-03-05 | — |
UPM+
- DG02176HAEMATURIADSTP_clinical_signs_-_haematuria
Variant (sleepy_king)
HEART (CARDIAC) VALVE DISORDER
DSTP_heart_condition_-_valve_disorder
Conf: 0.840
Threshold: 0.70
Above: ✓
Correct?
Acceptable?
Reason (not acceptable — misleading)
Diagnosis description